Category Archives: Health

What is new in the field of Health. Trending topics, and cutting edge research in the are of Health. Press Releases that give us updates on Health.

Face Expert Dr. Natalia Vidal Laureano Joins Exclusive Haute Beauty Network


Knowing surgery was her calling, Dr. Vidal did her General Surgery Residency at the University of Puerto Rico. Her leadership skills and hard work gave her the honor of becoming administrative chief resident during her final year.

During this time, she developed her love for plastic and reconstructive surgery, which led her to pursue her first fellowship in burn and reconstructive surgery at Albert Einstein College of Medicine in New York City.

Dr. Vidal then moved to Miami, to complete her second fellowship in plastic and reconstructive surgery at the prestigious University of Miami. During this time, she developed her passion for aesthetic surgery while training with experienced surgeons in her field.

Learn more about Dr. Natalia Vidal Laureano by visiting: https://hauteliving.com/hautebeauty/member/dr-natalia-vidal-laureano/

ABOUT HAUTE BEAUTY NETWORK:

Haute Beauty is affiliated with the luxury lifestyle publication Haute Living. As a section of Haute Living magazine, Haute Beauty covers the latest advancements in beauty and wellness, providing readers with expert advice on aesthetic and reconstructive treatments through its network of acclaimed doctors and beauty experts.

For more about Haute Beauty, visit https://hauteliving.com/hautebeauty/

Media Contact

Grace Sarkisian, Haute Beauty by Haute Living, (813)-260-0767, [email protected], https://hauteliving.com/hautebeauty/

SOURCE Haute Beauty by Haute Living

CURAE Appoints Gary Johnson as New Chief Growth Officer


Key accomplishments in Gary’s impressive career include his transformative work at R1 RCM, where he relaunched a struggling company in rebranded form to become a leader in RCM outsourcing. There, he recruited an 11-member marketing team to drive demand generation, solution marketing, and brand management, resulting in over $130 million in annual revenue. At MedAssets, Gary helped achieve a remarkable 10x revenue growth in the SaaS RCM and Supply Chain sectors, integrated 14 acquisitions, and led a successful IPO on Nasdaq (MDAS) as the leading brand in healthcare financial performance improvement, demonstrating his prowess in strategic growth and market expansion.

“I am thrilled to welcome Gary to our team. His extraordinary track record and deep expertise in both the B2B/CPG and healthcare SaaS sectors make him an invaluable addition to CURAE,” said Christopher Stenglein, CEO of CURAE. “His strategic vision and proven ability to drive growth align perfectly as we continue to expand and innovate the patient financial experience.”

“I am truly excited to join the CURAE team,” said Gary Johnson. “This is a pivotal time for the company, and I look forward to leveraging my experience to propel CURAE to its next level of growth, ensuring we continue to deliver exceptional value to our strategic partners and their patients.”

About CURAE:

Based in Atlanta, CURAE is the operational platform that seamlessly integrates patient advocacy, sponsorship, payments, and finance to optimize patient access and expand financial inclusion. With a focus on removing provider risk and expense, CURAE offers robust data and analytics at your fingertips. The platform is designed to solve patient affordability issues and remove provider financial risk, providing a simple yet complete financial experience for both patients and healthcare providers. For more information about CURAE and its solutions, please visit https://curae.com/

Media Contact

Tito Alvarez, CURAE, 1 678-643-9577, [email protected], https://curae.com/

Twitter, LinkedIn

SOURCE CURAE



What do Texas Doctors and Nurses Want this Thanksgiving? For You Not to Fill Their Emergency Rooms


SignatureCare Emergency Center’s board-certified emergency medicine physician, Dr. Christopher Langan says there are steps you can take to keep you and your family out of the ER this Thanksgiving.

HOUSTON, Texas, Nov. 16, 2023 /PRNewswire-PRWeb/ — Texans, your local emergency room physicians and nurses have one wish this Thanksgiving season – to have you stay safe and healthy, and enjoy the season with your family and friends.

Every Thanksgiving, local emergency rooms throughout Texas see a spike in weather-related injuries and most of those injuries are preventable. These illnesses and injuries can range from frostbites and hypothermia to auto accidents and other injuries.

“Most of these illnesses and injuries are preventable. Taking simple steps can prevent most injuries that we see during this time of the year,” said Dr. Christopher Langan, a board-certified emergency room physician and SignatureCare Emergency Center’s Chief Medical Officer (CMO).

Dr. Langan said SignatureCare is currently not experiencing an upward swing in the number of injuries or illnesses presented in the emergency rooms, but he cautioned that it is still early in the season.

“We have not seen any major changes in the number of weather-related illnesses or injuries in our emergency rooms so far but this is just the beginning of the cold season. As families come together to celebrate Thanksgiving and Christmas it is important that we exercise caution,” he said.

He advised taking steps to prevent accidents and weather-related injuries, and spreading illnesses like COVID, Respiratory Syncytial Virus (RSV) and the common cold or influenza.

“If you are going to gather together with family and friends this Thanksgiving, doing simple things like masking up while indoors, washing hands frequently and keeping a short distance from others will go a long way towards ensuring everyone in your family enjoys the festivities.

“Another thing to be mindful of is cooking injuries. Burns from overflowing and boiling oil, and extremely hot handles and lids could be severe and require an emergency room visit, so guard against that as well,” he added.

In 2021 when Texas experienced an unprecedented freeze, local emergency rooms were inundated with patients suffering from frostbites, hypothermia and auto accidents. Dr. Langan said one way to prevent auto accidents is not to drive unless you must.

“If you are not on the road, you will not have to worry about getting into auto accidents which could result in head, spine, neck and back injuries. Chest and abdominal injuries can also result from seat belts worn incorrectly – too high on the abdomen instead of across the hips,” Dr. Langan said.

Cold temperatures also lead to falls, especially by the elderly and Dr. Langan said these can be prevented as well.

“A lot of people, especially the elderly, are injured during cold temperatures. These injuries occur when they step outside without realizing that the sidewalks, porches or driveways are covered in ice. They slip and fall causing hip, back, leg and arm fractures, or head and brain injuries. These are all preventable. All we need to do is stay indoors,” he added.

Dr. Langan also advised covering up if you plan to be outside during the cold season.

“We are going to have cold days between now and the end of the year and if you plan to be outside, it is important to be covered to prevent hypothermia, frostbite and other issues. Take steps to protect yourself and your family and you will have a merry and enjoyable holiday season,” he said.

About SignatureCare Emergency Center

Houston, TX-based SignatureCare Emergency Center own 24-hour emergency centers throughout Texas, including Killeen, Austin, College Station/Bryan, Paris, Midland, Odessa, Texarkana, Pflugerville, and Lewisville, TX. 

Media Contact

Felix Ofiwe, SignatureCare Emergency Center, 832-699-3777, [email protected], https://ercare24.com

SOURCE SignatureCare Emergency Center

Breast Expert Dr. Garrett Wegerif Joins Exclusive Haute Beauty Network


He has a bachelor’s degree with honors in science and biology from the University of South Florida and a Doctor of Medicine with honors from Ross University School of Medicine. Dr. Wegerif completed his general surgery residency at the prestigious Cleveland Clinic Florida where he served as chief resident. He then completed a residency in plastic and reconstructive surgery at the University of New Mexico and earned a chief resident position in his final year. He is board-certified by the American Board of Surgery and board-eligible by the American Board of Plastic Surgery. His extensive knowledge is featured in multiple-authored and co-peer-reviewed medical journal articles and book chapters.

Dr. Wegerif is a Florida native from the Space Coast, and he lives with his family in Fort Lauderdale. He enjoys boating, traveling, and fitness.

Learn more about Dr. Garrett Wegerif by visiting: https://hauteliving.com/hautebeauty/member/dr-garrett-wegerif/

ABOUT HAUTE BEAUTY NETWORK:

Haute Beauty is affiliated with the luxury lifestyle publication Haute Living. As a section of Haute Living magazine, Haute Beauty covers the latest advancements in beauty and wellness, providing readers with expert advice on aesthetic and reconstructive treatments through its network of acclaimed doctors and beauty experts.

For more about Haute Beauty, visit https://hauteliving.com/hautebeauty/

Media Contact

Grace Sarkisian, Haute Beauty by Haute Living, (813)-260-0767, [email protected], https://hauteliving.com/hautebeauty/

SOURCE Haute Beauty by Haute Living

Patient Engagement, Digital Therapeutics and Social Determinants of Health in Cardiometabolic Drug Development, Upcoming Webinar Hosted by Xtalks


Characterizing social determinants of health in development programs by means of validated psychometric and behavioral instruments is critical to begin deriving digital therapeutics to mitigate this gap effectively.

When engaging in patient-focused drug development, it’s imperative to have a holistic approach to individuals, their predispositions and their life choices to embrace the whole human that ultimately will benefit from the innovation. This can only happen when insights are captured through a seamless site and patient experience solution.

Join this webinar to explore the importance of social determinants of health in achieving optimal health outcomes for cardiometabolic diseases, such as obesity, type 2 diabetes and ischemic heart disease. The featured speakers will discuss the promise of digital therapeutics to augment drug therapeutic interventions. The experts will also discuss recent FDA guidance and share their vision of the future of Lupus research and opportunities to drive Lupus research forward.

Join Dr. C. Michael Gibson (moderator), Baim Institute for Clinical Research; Professor of Medicine – Harvard Medical School; Interventional Cardiologist – Beth Israel Deaconess Medical Center; Dr. Christian Born Djurhuus, Owner, Djurhuus Consulting; Mona Khalid, VP, Value Demonstration, Health Economics and Patient Access, Endpoint Health Inc.; Kevin Golgin, Co-Founder, Observia Group; and Dr. Jonathan Goldman, CEO, Clinical Ink, for the live webinar on Tuesday, December 5, 2023, at 10am EST (4pm CET/EU-Central).

For more information, or to register for this event, visit Patient Engagement, Digital Therapeutics and Social Determinants of Health in Cardiometabolic Drug Development.

Media Contact

Vera Kovacevic, Xtalks, +1 (416) 977-6555 x371, [email protected]

SOURCE Xtalks

Powering the AI Revolution for Drug Discovery with High-Quality Empirical Data, Upcoming Webinar Hosted by Xtalks


1859’s discovery engine has the capacity to generate millions of active and inactive data points with embedded structure-activity relationships (SAR). To generate high-quality datasets, AI is used to inform diversity or focused library design of drug-like, combinatorial libraries, which are screened in biologically relevant assays with dose-response readouts. Ultimately, this results in high rates of true positive and true negative data points, and exceptionally high activity confirmation rates. This approach uncovers novel hits for multiple targets and modalities and constructs robust AIML models with the proprietary screening data generated.

The ability to rapidly produce high-quality datasets at scale to train AIML models opens doors for pursuing “undruggable” targets, novel modalities, and emerging resistance mutations, all with limited and sparse public data available. Beyond optimizing for potency and selectivity, advancements in AI can synergistically optimize molecules throughout the pipeline beyond hit finding, tackling drug metabolism, pharmacokinetics, toxicity and other necessary biological criteria.

Join this webinar to gain insights into how data disrupts the drug discovery paradigm and ultimately delivers new medicines to patients faster.

Join experts from 1859, Sara Thrall Cortese, PhD, Co-founder, Scientific Lead; Andrew MacConnell, PhD, Co-founder, Scientific Fellow; Deirdre Olynick, PhD, MBA, VP Partnerships and Portfolio, for the live webinar on Tuesday, December 5, 2023, at 10am PST (1pm EST).

For more information, or to register for this event, visit Powering the AI Revolution for Drug Discovery with High-Quality Empirical Data.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars and digital content to the global life science, food, healthcare and medical device communities. Every year, thousands of industry practitioners (from pharmaceutical, biotechnology, food, healthcare and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps professionals stay current with industry developments, regulations and jobs. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com
For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/

Media Contact

Vera Kovacevic, Xtalks, +1 (416) 977-6555 x371, [email protected]

SOURCE Xtalks

Clario’s Oncology Webinar Series Part 2 — Using Scientific Validation to Move the Needle on Accessibility Functionalities, Upcoming Webinar Hosted by Xtalks


Join experts from Clario, Bryan McDowell, Vice President, eCOA Clinical Science & Consulting; Dr. Kelly Dumais, PhD, Director, eCOA Science and Consulting; and Dr. Sarah Gary, PhD, eCOA Senior Science Advisor, for the live webinar on Monday, December 04, 2023, at 11am EST (4pm GMT/UK). This webinar is Part 2 of Clario’s Oncology Webinar Series.

For more information, or to register for this event, visit Clario’s Oncology Webinar Series.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com
For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/

Media Contact

Vera Kovacevic, Xtalks, +1 (416) 977-6555 x371, vkovacevic@xtalks.com

SOURCE Xtalks

Unleashing the Potential of ADCs with High-Quality Bioreagents, Upcoming Webinar Hosted by Xtalks


BIOVECTRA offers a range of benefits in ADC manufacturing, ensuring the highest quality outcomes for projects. One such advantage lies in the utilization of current good manufacturing practice (cGMP) grade DHAA (Dehydroascorbic acid) and TCEP (tris(2-carboxyethyl phosphine)) reagents. These high-quality materials are crucial in conjugation chemistry, facilitating efficient and precise antibody-drug conjugation.

Join this webinar to gain insights into the advantages of utilizing cGMP grade DHAA and TCEP in ADC manufacturing and the effective approaches for addressing potency testing and product purity challenges.

Join experts from BIOVECTRA, Jean-Francois Vincent-Rocan, Director of Complex Chemistry Process Development; and Alex Hendry, Project Manager — Business Development & Marketing, for the live webinar on Thursday, December 14, 2023, at 10am EST (3pm GMT/UK).

For more information, or to register for this event, visit Unleashing the Potential of ADCs with High-Quality Bioreagents.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com
For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/

Media Contact

Vera Kovacevic, Xtalks, +1 (416) 977-6555 x371, [email protected]

SOURCE Xtalks

Cytonus expands its Scientific Advisory Board with Oncolytic Virus expert John C. Bell, PhD


“I am excited to join the Cytonus Scientific Advisory Board, they are developing a transformative technology for the delivery of a range of immunotherapeutics and I look forward to contributing to the advancement of the Cargocyte platform.” said John Bell, PhD.

“The expertise and decades of research Professor Bell brings to Cytonus is invaluable. There is arguable no better example of a promising class of therapeutics that has more of a need for a delivery solution than oncolytic viruses. We have a highly differentiated delivery solutions for all virus based therapeutics and vaccines, and we want to enable the practical and safe use of viruses as a therapeutic choice. The Cargocyte platform for viral systemic transport solution and its acceptance within the viral immunotherapeutic world is resonating. We are very excited to work with Professor Bell on building on our existing oncolytic viral pipeline.” commented Cytonus’ cofounder and CEO Remo Moomiaie-Qajar, MD.

Cytonus’ Scientific Advisory Board is comprised of accomplished business leaders, distinguished research scientists, and key opinion leaders from prestigious academic institutions, immune-oncology centers, cell therapy centers, and private industry.

John C. Bell, PhD, is Senior Scientist at the Ottawa Hospital Research Institute and Professor in the University of Ottawa Departments of Medicine and Biochemistry, Microbiology and Immunology. Dr. Bell leads the Canadian Oncolytic Virus Consortium, a Terry Fox funded group from across Canada that is developing virus-based cancer therapeutics. At the Ottawa Hospital Cancer Center, he is a member of the Center for Cancer Therapeutics. He is the Scientific Director of BioCanRx, Canada’s Immunotherapy Network developing biotherapeutics for Cancer Therapy; and is a fellow of the Royal Society of Canada and a Fellow of the Canadian Academy of Health Sciences. Dr. Bell received his PhD from McMaster University in 1982. The three years that followed, he trained as a post-doctoral fellow at the University of Ottawa and then at the Medical Research Council in London, England. Dr. Bell began his independent research career at McGill University in 1986 and moved to the University of Ottawa Department of Medicine in 1989.

About Cytonus Therapeutics, Inc.

Cytonus is a San Diego-based biotech company that has developed a vast platform of proprietary immunotherapeutic products to treat a wide range of medical conditions including cancers, infectious diseases, inflammatory diseases, and cognitive disorders, and to improve patient outcomes. Its proprietary Cargocyte™ technologies are next-generation biomolecular delivery devices which have numerous medical applications across unmet therapeutic areas. Cargocytes™ are engineered to safely transport a multiplicity of therapeutic payloads into difficult-to-reach targeted tissues, and can be programmed to deliver selective, potent, and controllable “off-the-shelf” therapies.

For more information, we invite you to visit the Cytonus website at www.cytonus.com . Please follow us on Cytonus on LinkedIn and on Twitter “X” at: @CytonusTx.

Contact: [email protected] 

Statements in this news release other than strictly historical facts, such as statements about Cytonus’ plans and strategies, new and existing products, and technologies, anticipated clinical and regulatory pathways, and markets for its products, are forward-looking statements. The words “believe,” “expect,” “aim,” “anticipate,” “estimate,” “project,” and similar expressions identify forward-looking statements that speak only as of the date hereof. Such statements involve risks and uncertainties that could cause actual results to differ materially from anticipated results due to many factors, including regulatory and development risks. The company undertakes no obligation to publicly update or revise any forward-looking statement. This news release is neither an offer to sell, nor the solicitation of any offer to purchase, any security.

Media Contact

Remo Moomiaie-Qajar, Cytonus Therapeutics, Inc., 1 4423251113, [email protected], www.cytonus.com 

SOURCE Cytonus Therapeutics, Inc.

The Global Wellness Summit Honors Diverse Group of Pioneers for Their Achievements in Mental Wellness, Innovation and the Science of Wellness


“We’re thrilled to recognize the incredible achievements of Simone Biles at this year’s Global Wellness Summit, both as a superhuman athlete and a deeply human champion for mental wellbeing,” said Susie Ellis, GWS chair & CEO. “Superstars like Simone have the most powerful global megaphones, and she has brought attention to the mental health crisis, and the way we perceive mental health in the sporting world, in a way that almost no one else could.”

The Debra Simon Award for Furthering Mental Wellness was presented to Biles by the CEO of Fountain Life Bill Kapp, MD, on behalf of the GWS Advisory Board. Debra Simon’s daughter Lauren Wright, president of The Debra Simon Family Foundation, introduced the award.

Anjan Chatterjee, MD, for Innovation: Dr. Chatterjee, professor of neurology at the Perelman School of Medicine at the University of Pennsylvania, received the Leader in Innovation Award, sponsored by Kohler Co. Chatterjee was honored for his fascinating work in neuroaesthetics, which investigates the neural systems that underlie aesthetic experiences. He is the founding director of the Penn Center for Neuroaesthetics, a unique academic think-tank that focuses on beauty and morality (how our brains automatically respond to beauty and how those responses have consequences in our attitudes, biases and behavior); the built environment and wellness (investigating how environments and architecture affect our sense of wellbeing); and engagement with art (exploring the human decorative/aesthetic impulse and the paradox that seemingly non-utilitarian features of objects have such a persistent grip on us). He is also the author of “The Aesthetic Brain: How We Evolved to Desire Beauty and Enjoy Art,” which uses neuroscience and evolutionary psychology to examine how an aesthetic sense is etched into our minds. The book addresses fundamental questions such as: What is beauty? Is it universal? How is beauty related to pleasure? What is art? Should art be beautiful? Do we have an instinct for art?

The Leader in Innovation Award, sponsored by Kohler Co. and introduced by Ashley Kohler was presented to Chatterjee on behalf of GWS Advisory Board by Six Senses’ Anna Bjurstam.

Michael Roizen, MD, for the Science of Wellness: Dr. Roizen, a globally renowned pioneer in integrative medicine and longevity, received the Bennett Family Award for Collaboration in the Science of Wellness. Roizen is an anesthesiologist and internist, serves as Chief Wellness Officer at the Cleveland Clinic (the first such position in a major healthcare institution in the US), has authored 165 peer-reviewed medical publications, has 14 patents, and has served as a physician to Nobel laureates and Fortune 500 CEOs. If longevity is the hottest topic in 2023, Dr. Roizen was investigating the scientific basis for extending healthspan decades ago, as the founder of the RealAge concept, an evidence-based program that calculates the aging effect of more than 100 different health behaviors. The program enables people to assess their true biological age, and gives them a specific roadmap for improving their aging trajectory. He is the author of five number one New York Times best sellers, from the groundbreaking “RealAge: Are You as Young as You Can Be?” published in 1999 to his recent co-authored book, “The Great Age Reboot: Cracking the Longevity Code for a Younger Tomorrow.”

The Bennett Family Award for Collaboration in the Science of Wellness was presented to Roizen on behalf of the GWS Advisory Board by Nicola Finley, MD. Bija Bennett, who funds the endowment in memory of her parents, introduced the award.

About the Global Wellness Summit: The Global Wellness Summit is an organization that brings together leaders and visionaries to positively shape the future of the $5.6 trillion global wellness economy. In addition to an annual conference, held at a different location around the globe, GWS also hosts regular virtual gatherings, including Wellness Master Classes and collaborative Wellness Sector Spotlights, and each year holds an in-person Wellness Real Estate & Communities Symposium. The organization’s annual Global Wellness Trends Report offers expert-based predictions on the future of wellness that are oft-quoted in the media. The 18th annual GWS will be held in St. Andrews, Scotland, November 4-7, 2024.

Media Contact

Cassandra Cavanah, Global Wellness Summit, 8183974630, [email protected], https://www.globalwellnesssummit.com/

SOURCE Global Wellness Summit